Evidence map›Paper›PMID 35215213›Full record

ReviewPathogens (Basel, Switzerland)2022

Methods of Inactivation of Highly Pathogenic Viruses for Molecular, Serology or Vaccine Development Purposes.

Simon Elveborg, Vanessa M Monteil, Ali Mirazimi

Abstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Hantavirus stability and inactivation.PLoS neglected tropical diseases · 2026
    Article
  6. Review
  7. Discrimination betweenOne health (Amsterdam, Netherlands) · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Medical Gas Plasma Inactivates Adenoviruses via Capsid Oxidation.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Simon ElveborgDepartment of Clinical Microbiology, Uppsala University Hospital, 751 85 Uppsala, Sweden.
Vanessa M MonteilDepartment of Laboratory Medicine, Karolinska Institutet, 141 52 Huddinge, Sweden.ORCID 0000-0002-2652-5695
Ali MirazimiDepartment of Laboratory Medicine, Karolinska Institutet, 141 52 Huddinge, Sweden.

Funding

Innovative Medicines Initiative 823666
6 · The paper itself

Abstract

The handling of highly pathogenic viruses, whether for diagnostic or research purposes, often requires an inactivation step. This article reviews available inactivation techniques published in peer-reviewed journals and their benefits and limitations in relation to the intended application. The bulk of highly pathogenic viruses are represented by enveloped RNA viruses belonging to the

Indexed as

1.5-iodonaphtyl azidealdehydesaromatic disulfidesBeta-propiolactonechaotriopic saltsdetergentgamma-irradiationheathydrogen peroxideimmunoassaypsoralensSARS-CoV-2UV-radiation

Identifiers

PMID35215213
PMCPMC8879476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.